Sandra Kim, MD, is the Co-Director of the nationally recognized Center for Pediatric and Adolescent Inflammatory Bowel Disease within the Division of Gastroenterology, Hepatology and Nutrition. She is an associate professor of clinical pediatrics at the Ohio State University College of Medicine. Dr. Kim’s clinical and research interests focus on pediatric inflammatory bowel diseases, including adolescent transitioning and quality improvement in pediatric IBD and the impact of the gastrointestinal microbiota in IBD. Her research has been funded by the NIH and the Crohn’s and Colitis Foundation of America (CCFA) and has authored numerous studies on pediatric and adolescent inflammatory bowel diseases. Dr. Kim currently serves as past chair of Pediatric Affairs and current co – chair of Government Affairs/Advocacy for the CCFA nationally. In addition, she chairs the Clinical Practice and Adolescent Transitioning committees and serves on the Physician Leadership committee and Strategy Council for ImproveCareNow, a national, multi-institution collaborative focusing on improving outcomes in IBD patients. Dr. Kim also is involved as a member of the Medical Advisory Board for Flying Horse Farms and on the board of Directors for the Central Ohio CCFA chapter. As a reflection of her dedication to her profession, Dr. Kim was awarded the 2011 Rosenthal Award for her leadership in patient education and advocacy by the CCFA. She also was the 2015 faculty inductee at the Ohio State University College of Medicine chapters of Gold Humanism Honor Society and Alpha Omega Alpha.
Learn more about Sandra Kim, MD, medical director of our nationally recognized Inflammatory Bowel Disease (IBD) Center.